SCHEMBL4753735

SCHEMBL4753735

CC(C)[AsH]c1nc2ccc(C(C#N)C(=O)c3ccccc3F)nc2s1

nearest known ligand 0.34

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.32
RAB9A P51151 4/20 0.32
MEN1 O00255 3/20 0.32
KMT2A Q03164 3/20 0.32
S1PR1 P21453 2/20 0.31
S1PR3 Q99500 2/20 0.31
MAPT P10636 2/20 0.31
HPGD P15428 1/20 0.31
CES2 O00748 1/20 0.31
CES1 P23141 1/20 0.31
SMN1; SMN2 Q16637 3/20 0.31
ALDH1A1 P00352 1/20 0.31
TP53 P04637 1/20 0.31
HTT P42858 1/20 0.31
CFTR P13569 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2270437 0.82 RAB9A (0.38) NPC1RAB9AMEN1KMT2AMAPT
SCHEMBL13962776 0.69 CES2 (0.37) NPC1RAB9AMEN1KMT2AMAPT
SCHEMBL2273613 0.66 ALDH1A1 (0.35) NPC1RAB9AMEN1KMT2AMAPT
SCHEMBL2278283 0.66 USP8 (0.35) NPC1RAB9AMEN1KMT2AMAPT
SCHEMBL19925907 0.65 CES2 (0.47) NPC1RAB9AMEN1KMT2AMAPT
SCHEMBL29875006 0.65 CES2 (0.47) NPC1RAB9AMEN1KMT2AMAPT
SCHEMBL31468409 0.64 CES2 (0.50) NPC1RAB9AMEN1KMT2AMAPT
SCHEMBL2274683 0.63 MAPK14 (0.47) NPC1RAB9AMEN1KMT2AMAPT
SCHEMBL2274679 0.63 MAPK14 (0.47) NPC1RAB9AMEN1KMT2AMAPT
SCHEMBL12373218 0.63 SMN1; SMN2 (0.34) MEN1KMT2ACES2CES1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1910348-A2 BENZOTHIAZOLE AND AZABENZOTHIAZOLE COMPOUNDS USEFUL AS KINASE INHIBITORS Bristol-Myers Squibb Company (US) 2008-04-16 EP disclosed
WO-2007016392-A2 BENZOTHIAZOLE AND AZABENZOTHIAZOLE COMPOUNDS USEFUL AS KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2007-02-08 WO disclosed